Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/PRX-07034> ?p ?o }
Showing triples 1 to 77 of
77
with 100 triples per page.
- PRX-07034 abstract "PRX-07034 is a selective 5-HT6 receptor antagonist. It has cognition and memory-enhancing properties and potently decreases food intake and body weight in rodents. PRX-07034 was under development by Epix Pharmaceuticals for the treatment of obesity and cognitive impairment associated with Alzheimer's disease and schizophrenia but upon the company collapsing due to lack of funds the compound was auctioned to another corporation.".
- PRX-07034 atcPrefix "none".
- PRX-07034 casNumber "?".
- PRX-07034 iupacName "N-[1-(5-chloro-2,3-dimethoxyphenyl)ethyl]-2-methylsulfonyl-5-piperazin-1-ylaniline".
- PRX-07034 pubchem "11532574".
- PRX-07034 thumbnail PRX-07034_structure.png?width=300.
- PRX-07034 wikiPageExternalLink 5415458-1.html.
- PRX-07034 wikiPageExternalLink Epixs-Experimental-Drug-PRX-07034-Shows-Potential-Benefit-on-Cognition-Obesity-10689.html.
- PRX-07034 wikiPageID "26483314".
- PRX-07034 wikiPageLength "5191".
- PRX-07034 wikiPageOutDegree "16".
- PRX-07034 wikiPageRevisionID "673939599".
- PRX-07034 wikiPageWikiLink 5-HT6_receptor.
- PRX-07034 wikiPageWikiLink Alzheimers_disease.
- PRX-07034 wikiPageWikiLink Binding_selectivity.
- PRX-07034 wikiPageWikiLink Category:Anilines.
- PRX-07034 wikiPageWikiLink Category:Chloroarenes.
- PRX-07034 wikiPageWikiLink Category:Phenol_ethers.
- PRX-07034 wikiPageWikiLink Category:Piperazines.
- PRX-07034 wikiPageWikiLink Cognition.
- PRX-07034 wikiPageWikiLink Cognitive_deficit.
- PRX-07034 wikiPageWikiLink Eating.
- PRX-07034 wikiPageWikiLink Epix_Pharmaceuticals.
- PRX-07034 wikiPageWikiLink Human_body_weight.
- PRX-07034 wikiPageWikiLink Memory.
- PRX-07034 wikiPageWikiLink Obesity.
- PRX-07034 wikiPageWikiLink Receptor_antagonist.
- PRX-07034 wikiPageWikiLink Schizophrenia.
- PRX-07034 wikiPageWikiLinkText "PRX-07034".
- PRX-07034 atcPrefix "none".
- PRX-07034 c "21".
- PRX-07034 casNumber "?".
- PRX-07034 cl "2".
- PRX-07034 h "29".
- PRX-07034 iupacName "N-[1-ethyl]-2-methylsulfonyl-5-piperazin-1-ylaniline".
- PRX-07034 legalStatus "Uncontrolled".
- PRX-07034 molecularWeight "490.44".
- PRX-07034 n "3".
- PRX-07034 o "4".
- PRX-07034 pubchem "11532574".
- PRX-07034 routesOfAdministration "Oral".
- PRX-07034 s "1".
- PRX-07034 smiles "COc2ccccCNc1ccN3CCNCC3".
- PRX-07034 verifiedrevid "424987327".
- PRX-07034 wikiPageUsesTemplate Template:Anorectics.
- PRX-07034 wikiPageUsesTemplate Template:Antidementia.
- PRX-07034 wikiPageUsesTemplate Template:Drugbox.
- PRX-07034 wikiPageUsesTemplate Template:Nootropics.
- PRX-07034 wikiPageUsesTemplate Template:Reflist.
- PRX-07034 wikiPageUsesTemplate Template:Serotonergics.
- PRX-07034 subject Category:Anilines.
- PRX-07034 subject Category:Chloroarenes.
- PRX-07034 subject Category:Phenol_ethers.
- PRX-07034 subject Category:Piperazines.
- PRX-07034 hypernym Antagonist.
- PRX-07034 type ChemicalSubstance.
- PRX-07034 type Drug.
- PRX-07034 type Chemical.
- PRX-07034 type Drug.
- PRX-07034 type Enamine.
- PRX-07034 type Ether.
- PRX-07034 type Heterocycle.
- PRX-07034 type Organohalide.
- PRX-07034 type Organohalide.
- PRX-07034 type ChemicalObject.
- PRX-07034 type Thing.
- PRX-07034 type Q8386.
- PRX-07034 comment "PRX-07034 is a selective 5-HT6 receptor antagonist. It has cognition and memory-enhancing properties and potently decreases food intake and body weight in rodents. PRX-07034 was under development by Epix Pharmaceuticals for the treatment of obesity and cognitive impairment associated with Alzheimer's disease and schizophrenia but upon the company collapsing due to lack of funds the compound was auctioned to another corporation.".
- PRX-07034 label "PRX-07034".
- PRX-07034 sameAs Q855480.
- PRX-07034 sameAs m.0bbw75v.
- PRX-07034 sameAs PRX-07034.
- PRX-07034 sameAs PRX-07034.
- PRX-07034 sameAs Q855480.
- PRX-07034 wasDerivedFrom PRX-07034?oldid=673939599.
- PRX-07034 depiction PRX-07034_structure.png.
- PRX-07034 isPrimaryTopicOf PRX-07034.